drugset / Trial / NCT03453541

Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy

NCT03453541

Phase 4 Terminated 214 enrolled Albany Medical College
RandomizedParallel-groupDouble-blindTreatment

Summary

This prospective, randomized, double blinded study is designed to compare the bleeding rates of ketorolac vs. placebo when used for post tonsillectomy pain control in pediatric patients ages 2-18.

Timeline

Start
2017-11-21
Primary completion
2022-11-01
Completion
2022-11-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 0.5 mg/kg Intravenous

Indications

No indication recorded.